Volume 72, Issue 6, Pages (December 2017)

Slides:



Advertisements
Similar presentations
Volume 61, Issue 5, Pages (May 2012)
Advertisements

Early Detection of Prostate Cancer in 2007
Volume 55, Issue 1, Pages 1-8 (January 2009)
The PSA Era is not Over for Prostate Cancer
Volume 72, Issue 2, Pages (August 2017)
Volume 57, Issue 1, Pages (January 2010)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 58, Issue 4, Pages (October 2010)
Volume 73, Issue 3, Pages (March 2018)
European Urology Focus
Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer  Marisa Warmuth,
Volume 61, Issue 6, Pages (June 2012)
Volume 70, Issue 1, Pages (July 2016)
Volume 60, Issue 5, Pages (November 2011)
Volume 73, Issue 1, Pages (January 2018)
Volume 67, Issue 4, Pages (April 2015)
Volume 63, Issue 1, Pages (January 2013)
Courtney J. Warner, MD, MS, Spencer W. Greaves, MPH, Robin J
Volume 72, Issue 5, Pages (November 2017)
Volume 61, Issue 5, Pages (May 2012)
Volume 66, Issue 3, Pages (September 2014)
Volume 58, Issue 5, Pages (November 2010)
Volume 70, Issue 6, Pages (December 2016)
Volume 73, Issue 3, Pages (March 2018)
Volume 73, Issue 1, Pages (January 2018)
Volume 61, Issue 2, Pages (February 2012)
Prostate Cancer Epidemic in Sight?
Treatment of Nightmares With Prazosin: A Systematic Review
Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration- resistant Prostate Cancer in the Era of Precision Oncology  Philipp.
Volume 65, Issue 6, Pages (June 2014)
Re: Marcus G. Cumberbatch, Matteo Rota, James W. F
Volume 61, Issue 1, Pages (January 2012)
Volume 73, Issue 3, Pages (March 2018)
Volume 68, Issue 4, Pages (October 2015)
Volume 54, Issue 4, Pages (October 2008)
The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review
Volume 71, Issue 3, Pages (March 2017)
Volume 70, Issue 3, Pages (September 2016)
Prostate Cancer Detection: A View of the Future
Volume 74, Issue 2, Pages (August 2018)
Volume 71, Issue 3, Pages (March 2017)
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Volume 69, Issue 6, Pages (June 2016)
Volume 69, Issue 4, Pages (April 2016)
Volume 66, Issue 6, Pages (December 2014)
Prostate Cancer Epidemic in Sight?
The PSA Era is not Over for Prostate Cancer
Volume 71, Issue 4, Pages (April 2017)
Volume 61, Issue 5, Pages (May 2012)
Volume 72, Issue 1, Pages (July 2017)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 61, Issue 6, Pages (June 2012)
Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review  Sven van.
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Volume 62, Issue 3, Pages (September 2012)
Volume 73, Issue 3, Pages (March 2018)
Volume 62, Issue 6, Pages (December 2012)
Volume 72, Issue 2, Pages (August 2017)
Volume 50, Issue 5, Pages (November 2006)
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Volume 74, Issue 6, Pages (December 2018)
Volume 73, Issue 2, Pages (February 2018)
Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer  Amar U. Kishan, Rahul.
Jonathan S. Brajtbord, Michael S. Leapman, Matthew R. Cooperberg 
Measuring non-technical skills of anaesthesiologists in the operating room: a systematic review of assessment tools and their measurement properties 
Volume 75, Issue 1, Pages (January 2019)
Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.
Volume 52, Issue 6, Pages (December 2007)
Systematic Review of Complications of Prostate Biopsy
Volume 76, Issue 3, Pages (September 2019)
Presentation transcript:

Volume 72, Issue 6, Pages 869-885 (December 2017) Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review  Michael Lardas, Matthew Liew, Roderick C. van den Bergh, Maria De Santis, Joaquim Bellmunt, Thomas Van den Broeck, Philip Cornford, Marcus G. Cumberbatch, Nicola Fossati, Tobias Gross, Ann M. Henry, Michel Bolla, Erik Briers, Steven Joniau, Thomas B. Lam, Malcolm D. Mason, Nicolas Mottet, Henk G. van der Poel, Olivier Rouvière, Ivo G. Schoots, Thomas Wiegel, Peter-Paul M. Willemse, Cathy Yuhong Yuan, Liam Bourke  European Urology  Volume 72, Issue 6, Pages 869-885 (December 2017) DOI: 10.1016/j.eururo.2017.06.035 Copyright © 2017 European Association of Urology Terms and Conditions

Fig. 1 PRISMA flow diagram. QoL=quality of life; PCa=prostate cancer; PRISMA=Preferred Reporting Items for Systematic Reviews and Meta-analyses. European Urology 2017 72, 869-885DOI: (10.1016/j.eururo.2017.06.035) Copyright © 2017 European Association of Urology Terms and Conditions

Fig. 2 Risk of bias and confounder assessment for (A) RCTs and (B) nonrandomised prospective studies. Red colour indicates high RoB, yellow uncertain RoB, and green low RoB. RCT=randomised controlled trial; RoB=risk of bias. European Urology 2017 72, 869-885DOI: (10.1016/j.eururo.2017.06.035) Copyright © 2017 European Association of Urology Terms and Conditions